Category: Oncology/Hematology
Oncology/Hematology market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Clinical Oncology Next Generation Sequencing
The 2025-2030 World Outlook for Clinical Oncology Next Generation Sequencing This study covers the world outlook for clinical oncology next generation sequencing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.) ... Read More
-
The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests
The 2025-2030 World Outlook for Cancer Diagnostics Laboratory Tests This study covers the world outlook for cancer diagnostics laboratory tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Imaging Devices
The 2025-2030 World Outlook for Breast Cancer Imaging Devices This study covers the world outlook for breast cancer imaging devices across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Diagnostics
The 2025-2030 World Outlook for Ovarian Cancer Diagnostics This study covers the world outlook for ovarian cancer diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Ovarian Cancer Drugs
The 2025-2030 World Outlook for Ovarian Cancer Drugs This study covers the world outlook for ovarian cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Blood Cancer Therapeutics
The 2025-2030 World Outlook for Blood Cancer Therapeutics This study covers the world outlook for blood cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Generic Oncology Drugs
The 2025-2030 World Outlook for Generic Oncology Drugs This study covers the world outlook for generic oncology drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Blockbuster Oncology Brands
The 2025-2030 World Outlook for Blockbuster Oncology Brands This study covers the world outlook for blockbuster oncology brands across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Cancer Screenings
The 2025-2030 World Outlook for Cancer Screenings This study covers the world outlook for cancer screenings across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care
The 2025-2030 World Outlook for Cancer Supportive Care This study covers the world outlook for cancer supportive care across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Cancer Stem Cells
The 2025-2030 World Outlook for Cancer Stem Cells This study covers the world outlook for cancer stem cells across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs
The 2025-2030 World Outlook for Hodgkins Lymphoma Drugs This study covers the world outlook for Hodgkins lymphoma drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Blood-Product Hematology Drugs
The 2025-2030 World Outlook for Blood-Product Hematology Drugs This study covers the world outlook for blood-product hematology drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs
The 2025-2030 World Outlook for Endocrine Pancreatic Cancer Drugs This study covers the world outlook for endocrine pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies
The 2025-2030 World Outlook for Breast Cancer Diagnostics and Drug Technologies This study covers the world outlook for breast cancer diagnostics and drug technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care
The 2025-2030 World Outlook for Granulocyte Colony Stimulating Factor (G-CSF) Cancer Supportive Care This study covers the world outlook for granulocyte colony stimulating factor (g-CSF) cancer supportive care across more than 190 countries. For each year reported, estimates are given for the latent ... Read More
-
The 2025-2030 World Outlook for Hematology and Oncology Products
The 2025-2030 World Outlook for Hematology and Oncology Products This study covers the world outlook for hematology and oncology products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Cancer Testing-Screening
The 2025-2030 World Outlook for Cancer Testing-Screening This study covers the world outlook for cancer testing-screening across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Cancer Therapeutics
The 2025-2030 World Outlook for Cancer Therapeutics This study covers the world outlook for cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Radiation Oncology
The 2025-2030 World Outlook for Radiation Oncology This study covers the world outlook for radiation oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2025-2030 World Outlook for Pancreatic Cancer Drugs
The 2025-2030 World Outlook for Pancreatic Cancer Drugs This study covers the world outlook for pancreatic cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Immunotherapy Drugs
The 2025-2030 World Outlook for Immunotherapy Drugs This study covers the world outlook for immunotherapy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)
The 2025-2030 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for colorectal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2025-2030 World Outlook for Immuno-Oncology
The 2025-2030 World Outlook for Immuno-Oncology This study covers the world outlook for immuno-oncology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs
The 2025-2030 World Outlook for Targeted Therapy Liver Cancer Drugs This study covers the world outlook for targeted therapy liver cancer drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
Research Assistance
